Linda Marsh - Mar 4, 2020 Form 4 Insider Report for Apollo Medical Holdings, Inc. (AMEH)

Role
Director
Signature
/s/ Linda Marsh
Stock symbol
AMEH
Transactions as of
Mar 4, 2020
Transactions value $
$625,000
Form type
4
Date filed
3/13/2023, 12:40 PM
Next filing
May 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Options Exercise $625K +62.5K $10.00 62.5K Mar 9, 2023 Direct
holding AMEH Common Stock 270K Mar 4, 2020 By Alliance Apex, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMEH Stock Option (right to buy) Disposed to Issuer -62.5K -100% 0 Mar 4, 2020 Common Stock 62.5K $10.00 Direct F2
transaction AMEH Stock Option (right to buy) Award +62.5K 62.5K Mar 4, 2020 Common Stock 62.5K $10.00 Direct F2
transaction AMEH Stock Option (right to buy) Options Exercise $0 -62.5K -100% $0.00* 0 Mar 9, 2023 Common Stock 62.5K $10.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned directly by Alliance Apex, LLC, of which Reporting Person is a member and the sole manager. Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the filing of this report is not an admission that Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
F2 The transactions reported on Lines 1 and 2 involved an amendment of an outstanding option, resulting in the cancellation of the original option and the grant of a replacement option. The option was originally granted on April 5, 2017 and vested and became exercisable on a monthly basis over thirty six months commencing on May 5, 2017.
F3 The stock options were granted on March 4, 2020 and vested and became exercisable on the date of the grant.